Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL565348

O=P([O-])([O-])OP(=O)([O-])[O-].[H+].[K+].[K+].[K+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Pyrophosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.40
CA1 P00915 2/20 0.33
CA4 P22748 2/20 0.33
CA5A P35218 2/20 0.33
CA5B Q9Y2D0 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL18260586 1.00 SLC34A1 (0.40) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL565495 1.00 SLC34A1 (0.40) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL565180 1.00 SLC34A1 (0.40) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL728737 0.96 SLC34A1 (0.43) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL12474297 0.96 LMNA (0.35) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL118119 0.96 LMNA (0.35) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL196398 0.96
Pyrophosphoric Acid SCHEMBL9511742 0.96 SLC34A1 (0.43) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL565551 0.96 LMNA (0.35) SLC34A1CA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL18260581 0.96 LMNA (0.35) SLC34A1CA1CA4CA5ACA5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115845782-B Production method of high-solubility sodium-potassium crosslinked modified phosphate 湖北省兴发磷化工研究院有限公司 2025-06-24 CN claimed
US-12324871-B2 Absorbable iron-based alloy implanted medical device and manufacturing method thereof BIOTYX MEDICAL (SHENZHEN) CO., LTD. (CN) 2025-06-10 US claimed
CN-115845782-A Production method of high-solubility sodium-potassium crosslinking modified phosphate 湖北省兴发磷化工研究院有限公司 2023-03-28 CN claimed
EP-3378504-B1 ABSORBABLE IRON-BASED ALLOY IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREOF LIFETECH SCIENT (SHENZHEN) CO LTD (CN) 2020-09-23 EP claimed
CN-106693043-B Absorbable iron-based alloy implanted medical instrument and preparation method thereof 先健科技(深圳)有限公司 2020-06-16 CN claimed
CN-110840813-A Whitening composition and application thereof 上海绿瑞生物科技有限公司 2020-02-28 CN claimed
US-20180326128-A1 Absorbable Iron-based Alloy Implanted Medical Device and Manufacturing Method Thereof LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD. (CN) 2018-11-15 US claimed
EP-3378504-A1 ABSORBABLE IRON-BASED ALLOY IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREOF Lifetech Scientific (Shenzhen) Co., Ltd. (CN) 2018-09-26 EP claimed
US-9044466-B2 Oral compositions comprising a zinc compound and an anti-microbial agent THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2015-06-02 US claimed
EP-2600833-A2 ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT The Research Foundation for The State University of New York (US) 2013-06-12 EP claimed
WO-2012021415-A2 ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2012-02-16 WO claimed
US-20120034280-A1 ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2012-02-09 US claimed
EP-0881938-A4 NOVEL METHODS AND APPARATUS FOR OSMOTIC DISTILLATION RENTIERS MACHINERY PTY LTD (AU) 1999-04-14 EP claimed
EP-0881938-A1 NOVEL METHODS AND APPARATUS FOR OSMOTIC DISTILLATION Rentiers Machinery Proprietary Ltd. (AU) 1998-12-09 EP claimed
US-5824223-A Methods and apparatus for osmotic distillation RENTIERS MACHINERY PROPRIETARY LTD. (AU) 1998-10-20 US claimed
CN-115845782-B Production method of high-solubility sodium-potassium crosslinked modified phosphate 湖北省兴发磷化工研究院有限公司 2025-06-24 CN disclosed
US-12324871-B2 Absorbable iron-based alloy implanted medical device and manufacturing method thereof BIOTYX MEDICAL (SHENZHEN) CO., LTD. (CN) 2025-06-10 US disclosed
US-5824223-A Methods and apparatus for osmotic distillation RENTIERS MACHINERY PROPRIETARY LTD. (AU) 1998-10-20 US disclosed
WO-1997017128-A1 NOVEL METHODS AND APPARATUS FOR OSMOTIC DISTILLATION RENTIERS MACHINERY PROPRIETARY LTD. (AU) 1997-05-15 WO disclosed
US-5624906-A Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1997-04-29 US disclosed